Michael K. Schultz

Direttore Tecnico/Scientifico/R&S presso PERSPECTIVE THERAPEUTICS, INC.

Commercial Services

Health Technology

Consumer Services

Profilo

Michael K.
Schultz founded Viewpoint Molecular Targeting, Inc. in 2008, where he is working as Chief Science Officer from 2013.
Dr. Schultz also currently works at Perspective Therapeutics, Inc., as Chief Science Officer.
Dr. Schultz also formerly worked at the University of Iowa, as Associate Professor and National Institute of Health Policy, as Principal.

Posizioni attive di Michael K. Schultz

Società	Posizione	Inizio
PERSPECTIVE THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	-
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Fondatore	01/01/2008

Tutte le posizioni attive di Michael K. Schultz

Precedenti posizioni note di Michael K. Schultz

Società	Posizione	Fine
National Institute of Health Policy	Corporate Officer/Principal	-
University of Iowa	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Michael K. Schultz

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael K. Schultz

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
PERSPECTIVE THERAPEUTICS, INC.	Health Technology

Aziende private	2
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Commercial Services
National Institute of Health Policy